Adequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: Systematic review

CONCLUSION: With the exception of prostate cancer, the evidence base for monitoring low-risk cancer is weak and consequently recommendations in clinical guidelines are inconsistent. There is a lack of direct evidence to support monitoring recommendations in the literature making guideline developers reliant on expert opinion, alternative guidelines, or indirect or non-specific evidence.PMID:38360377 | DOI:10.1016/j.jclinepi.2024.111280

Source: Clinical Prostate Cancer - February 15, 2024 Category: Cancer & Oncology Authors: Kiana Collins Claire Friedemann Smith Tori Ford Nia Roberts Brian D Nicholson Jason Oke Source Type: research